Alzheimer's disease (AD) is characterized by the accumulation of beta‐amyloid (Aβ), tau, microglial activation, metabolic brain changes, neurodegeneration, and cognitive decline (Jack et al, 2018). The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.